CAPITAL OFFLOAD-SHOCK
NCT07756801 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 456
Last updated 2026-08-11
Summary
CAPITAL OFFLOAD-SHOCK will aim to answer if early use of renal replacement therapy, like dialysis, in patients with reduced body fluids causing the heart to be unable to pump enough blood through the body reduces in-hospital death when compared to the current standard of care. The current standard of care is to wait until renal replacement therapy is clinically necessary.
Conditions
- Hypervolemia
- Cardiogenic Shock
- Renal Replacement Therapy
Interventions
- DRUG
-
Immediate renal replacement therapy
Renal replacement therapy started within 6 hours of randomization
Sponsors & Collaborators
-
Ottawa Heart Institute Research Corporation
lead OTHER
Principal Investigators
-
Simon Parlow, MD, FRCPC · Ottawa Heart Institute Research Corporation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2027-09-30
- Completion
- 2031-09-30
Countries
- Canada
Study Locations
More Related Trials
-
CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure
NCT02079259 ·Status: COMPLETED
-
Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)
NCT00699712 ·Status: COMPLETED ·Phase: PHASE2
-
Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction
NCT00575484 ·Status: TERMINATED ·Phase: PHASE2
-
Hypertonic Saline Solution in Heart Failure
NCT00555685 ·Status: COMPLETED ·Phase: PHASE2
-
Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)
NCT02643147 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure
NCT00348556 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
NCT00186329 ·Status: COMPLETED ·Phase: PHASE4
-
Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome
NCT02846337 ·Status: UNKNOWN ·Phase: NA
-
Exogenous Ketones for Acutely Decompensated HEart Failure
NCT04698005 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure
NCT05298098 ·Status: UNKNOWN ·Phase: NA
-
Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
NCT02476409 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Diuretic Therapy for Acute Decompensated Heart Failure
NCT05840536 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of Tolvaptan in Japanese Patients With Acute Heart Failure
NCT01635517 ·Status: COMPLETED
-
Acetazolamide in Patients With Acute Heart Failure
NCT03720288 ·Status: UNKNOWN ·Phase: PHASE3
-
Cardiorenal Interactions During Treatment of Acute Decompensated Heart Failure: Diuretics Versus Ultrafiltration
NCT01138683 ·Status: COMPLETED ·Phase: PHASE3
-
Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction
NCT04919564 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
NCT01407900 ·Status: WITHDRAWN ·Phase: PHASE1
-
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
NCT07273838 ·Status: RECRUITING ·Phase: PHASE2
-
Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure
NCT06689553 ·Status: TERMINATED ·Phase: NA
-
Empagliflozin in Acute Heart Failure
NCT05305495 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study)
NCT00608491 ·Status: COMPLETED ·Phase: PHASE3
-
Infusion of Furosemide to Improve Diuretic Efficiency in Acute Heart Failure
NCT07577596 ·Status: RECRUITING ·Phase: PHASE4
-
Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
NCT04331132 ·Status: UNKNOWN ·Phase: NA
-
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload
NCT01508260 ·Status: WITHDRAWN ·Phase: NA